Condition: Dermatitis, Atopic · Sponsor: Fundación Academia Española de Dermatología
The Spanish Registry of Systemic therapy in atopic eczema, BIOBADATOP, assesses drug safety and treatment effectiveness as well as treatment impact on quality of life in children and adults with atopic eczema receiving systemic immuno-modulatory therapies in Spanish daily practice. The main objectives are: 1. To assess short and long-term safety of systemic therapies (including phototherapy) for atopic eczema (pharmacovigilance). 2. To assess short and long-term effectiveness of systemic therapies, providing a basis for shared decision making and guidelines. Secondary objectives are: 1. To assess short and long-term safety of topical therapies for atopic eczema. 2. To assess effectiveness of different methods of care, including patient training. 3. To describe atopic dermatitis comorbidities.
This description comes directly from the study's public registry record.
Ignacio Garcia-Doval · 34915 44 62 84 · investigacion@aedv.es
Miguel Angel Descalzo Gallego · 34915 44 62 84
Always discuss trial participation with your own doctor first.
| Hospital Universitari Germans Trias i Pujol | Badalona, Barcelona, Spain | Recruiting |
| Hospital General Universitario de Alicante | Alicante, Spain | Recruiting |
| Hospital del Mar IMIM | Barcelona, Spain | Recruiting |
| Hospital Universitario de Gran Canaria Dr Negrín | Las Palmas, Spain | Recruiting |
| Hospital Infanta Leonor | Madrid, Spain | Recruiting |
| Hospital Universitario de la Princesa | Madrid, Spain | Recruiting |
| Complexo Hospitalario Universitario de Pontevedra | Pontevedra, Spain | Recruiting |
| Hospital Universitario y Politécnico la Fe | Valencia, Spain | Recruiting |
| Hospital Miguel Servet | Zaragoza, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05674695